Probable transfusion-transmission of Anaplasma phagocytophilum by leukoreduced platelets

Rebecca L Townsend1, Erin D Moritz, Lawrence B Fialkow

  • 1Scientific Support Office, American Red Cross, Gaithersburg, Maryland.

Transfusion
|April 18, 2014
PubMed
Abstract

Insights

This study reports the first probable case of transfusion-transmitted human granulocytic anaplasmosis (HGA) via leukoreduced platelets (PLTs). An asymptomatic donor with tick exposure transmitted Anaplasma phagocytophilum (AP) through PLTs, highlighting a new risk for HGA transmission.

Area of Science:

  • Infectious Diseases
  • Hematology
  • Public Health

Background:

  • Anaplasma phagocytophilum (AP) causes human granulocytic anaplasmosis (HGA).
  • Seven cases of transfusion-transmitted HGA (TT-HGA) linked to red blood cells (RBCs) have been documented.
  • This report details the first suspected case of TT-HGA involving leukoreduced platelets (PLTs).

Observation:

  • A trauma patient receiving 25 blood components developed HGA.
  • The patient had no known risk factors for AP infection.
  • Diagnostic testing confirmed AP infection in the recipient.

Findings:

  • One of the 12 donors, a asymptomatic female from an endemic area, tested positive for AP via PCR and had high IgG levels.
  • This donor had a history of tick bites and no travel outside an endemic region.
  • The implicated PLT unit was transfused to another patient who died of unrelated causes.

Implications:

  • Leukoreduced platelets (PLTs) can transmit Anaplasma phagocytophilum (AP).
  • Asymptomatic, antibody-positive donors can transmit AP.
  • This finding necessitates re-evaluation of blood product safety protocols for AP.